These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21412012)

  • 41. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
    Wang LE; Ma H; Hale KS; Yin M; Meyer LA; Liu H; Li J; Lu KH; Hennessy BT; Li X; Spitz MR; Wei Q; Mills GB
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):377-85. PubMed ID: 22146979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
    Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
    Nutr Cancer; 2011 Nov; 63(8):1226-34. PubMed ID: 21999454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors.
    Bellmunt J; Werner L; Leow JJ; Mullane SA; Fay AP; Riester M; Van Hummelen P; Taplin ME; Choueiri TK; Van Allen E; Rosenberg J
    PLoS One; 2015; 10(6):e0124711. PubMed ID: 26039708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions.
    Waniczek D; Śnietura M; Młynarczyk-Liszka J; Pigłowski W; Kopeć A; Lange D; Rudzki M; Arendt J
    Pol J Pathol; 2013 Apr; 64(1):15-20. PubMed ID: 23625595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.
    Piao Y; Li Y; Xu Q; Liu JW; Xing CZ; Xie XD; Yuan Y
    PLoS One; 2015; 10(8):e0136447. PubMed ID: 26317520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.
    Hou MM; Liu X; Wheler J; Naing A; Hong D; Coleman RL; Tsimberidou A; Janku F; Zinner R; Lu K; Kurzrock R; Fu S
    Oncotarget; 2014 Nov; 5(22):11168-79. PubMed ID: 25426553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
    Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
    J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
    Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
    Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
    Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
    PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.
    Wang X; Lin Y; Lan F; Yu Y; Ouyang X; Wang X; Huang Q; Wang L; Tan J; Zheng F
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1399-411. PubMed ID: 24737346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.
    Yeung KS; Tso WWY; Ip JJK; Mak CCY; Leung GKC; Tsang MHY; Ying D; Pei SLC; Lee SL; Yang W; Chung BH
    Mol Autism; 2017; 8():66. PubMed ID: 29296277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
    Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
    Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.
    Qian DC; Xiao X; Byun J; Suriawinata AA; Her SC; Amos CI; Barth RJ
    Clin Cancer Res; 2017 Jan; 23(2):399-406. PubMed ID: 27435399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk.
    Ge Y; Liu H; Qiu X; Ma G; Wang H; Du M; Wang M; Zhao Q; Tao G; Chu H; Zhang Z
    Gene; 2018 Sep; 670():130-135. PubMed ID: 29802999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Akt-regulated pathways in prostate cancer.
    Majumder PK; Sellers WR
    Oncogene; 2005 Nov; 24(50):7465-74. PubMed ID: 16288293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144.
    Liu J; Xie S; Wu Y; Xu M; Ao C; Wang W; Zeng Q; Hu W; Li M
    Anticancer Drugs; 2016 Mar; 27(3):156-63. PubMed ID: 26645890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
    Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
    Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Insights into Colorectal Cancer: Evaluating PI3K/AKT Signaling Pathway Genes Expression.
    Świechowski R; Pietrzak J; Wosiak A; Mik M; Balcerczak E
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.